← Back to Search

Blue-Button Screening for Cancer Trials Enrollment

N/A
Waitlist Available
Led By Mark Fleury, PhD
Research Sponsored by American Cancer Society Cancer Action Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up quarterly surveys of research staff for the duration of the trial, up to 24 months.
Awards & highlights

Study Summary

This trial hopes to increase cancer trial enrollment by making it easier to identify potential trials & examining what stops patients from enrolling.

Who is the study for?
This trial is for adult cancer patients who are visiting the clinic and could be screened for clinical trial participation. It aims to integrate a new method of identifying suitable trials as part of routine care, potentially increasing enrollment and diversity in cancer clinical trials.Check my eligibility
What is being tested?
The Blue-Button screening process is being tested to see if it can improve the rate at which cancer patients enroll in clinical trials by making it easier to find relevant studies during regular healthcare visits.See study design
What are the potential side effects?
Since this study focuses on improving trial enrollment processes rather than testing a medical treatment, there are no direct side effects associated with the intervention itself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~quarterly surveys of research staff for the duration of the trial, up to 24 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and quarterly surveys of research staff for the duration of the trial, up to 24 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of clinical trial participation
Secondary outcome measures
Participant reports on Blue-button tool usability
Patient reasons for non-enrollment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Blue-button screeningExperimental Treatment1 Intervention
Subjects assigned to this arm will have deidentified data elements transferred from their EHR to the Blue-button tool for identification of clinical trials for which they may be eligible. After review by clinical research staff, appropriate trials will be offered to subjects.
Group II: Standard of CareActive Control1 Intervention
Subjects in this arm will receive the standard of care, either routine screening for clinical trials or no screening, according to standard institutional protocol. Potential clinical trials, if identified, will be offered to subjects according to the usual institutional process.

Find a Location

Who is running the clinical trial?

American Cancer Society Cancer Action NetworkLead Sponsor
Mark Fleury, PhDPrincipal InvestigatorACS CAN

Media Library

Blue-button screening Clinical Trial Eligibility Overview. Trial Name: NCT05885880 — N/A
Cancer Research Study Groups: Standard of Care, Blue-button screening
Cancer Clinical Trial 2023: Blue-button screening Highlights & Side Effects. Trial Name: NCT05885880 — N/A
Blue-button screening 2023 Treatment Timeline for Medical Study. Trial Name: NCT05885880 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open recruitment opportunities for this research endeavor?

"Data from clinicaltrials.gov reveals that this particular medical trial, which was initially listed on June 1st 2023, is not presently accepting participants. However, there are 527 other studies with open recruitment at the moment."

Answered by AI
~612 spots leftby Dec 2024